{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T08:50:29Z","timestamp":1746521429201},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00106-020-00890-5","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T12:02:53Z","timestamp":1590667373000},"page":"648-656","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Organerhalt beim fortgeschrittenen Larynx\u2011\/Hypopharynxkarzinom: Erfahrungen aus der DELOS-II-Studie"],"prefix":"10.1007","volume":"68","author":[{"given":"A.","family":"Dietz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kuhnt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,28]]},"reference":[{"key":"890_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"GT Wolf","year":"1991","unstructured":"The Department of Veterans Affairs Laryngeal Cancer Study Group; Wolf GT et al (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N\u00a0Engl J Med 324:1685\u20131690. https:\/\/doi.org\/10.1056\/NEJM199106133242402","journal-title":"Engl J Med"},{"issue":"12","key":"890_CR2","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1002\/lary.27800","volume":"129","author":"JF Petersen","year":"2019","unstructured":"Petersen\u00a0JF, Berlanga\u00a0A, Stuiver\u00a0MM, Hamming-Vrieze\u00a0O, Hoebers\u00a0F, Lambin\u00a0P, van den Brekel\u00a0MWM (2019) Improving decision making in larynx cancer by developing a\u00a0decision aid: a mixed methods approach. Laryngoscope 129(12):2733\u20132739. https:\/\/doi.org\/10.1002\/lary.27800","journal-title":"Laryngoscope"},{"issue":"S01","key":"890_CR3","first-page":"S60","volume":"99","author":"S Wiegand","year":"2020","unstructured":"Wiegand\u00a0S, Dietz\u00a0A (2020) Qualit\u00e4t in der Kopf-Hals-Onkologie. Laryngorhinotologie 99(S01):S60\u2013S106. (online Publikation, 16.03.2020, LRO)","journal-title":"Laryngorhinotologie"},{"key":"890_CR4","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","volume":"31","author":"AA Forastiere","year":"2013","unstructured":"Forastiere\u00a0AA, Zhang\u00a0Q, Weber\u00a0RS, Maor\u00a0MH, Goepfert\u00a0H, Pajak\u00a0TF et al (2013) Long-term results of RTOG 91-11: a\u00a0comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J\u00a0Clin Oncol 31:845\u2013852. https:\/\/doi.org\/10.1200\/JCO.2012.43.6097","journal-title":"J Clin Oncol"},{"key":"890_CR5","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1200\/JCO.2018.77.8001","volume":"36","author":"L Licitra","year":"2018","unstructured":"Licitra\u00a0L, Bonomo\u00a0P, Sanguineti\u00a0G, Bacigalupo\u00a0A, Baldi\u00a0GG, Valerini\u00a0S et al (2018) Different view on larynx preservation evidence-based treatment recommendations. J\u00a0Clin Oncol 36:1376\u20131377. https:\/\/doi.org\/10.1200\/JCO.2018.77.8001","journal-title":"J Clin Oncol"},{"key":"890_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/hed.23326","volume":"36","author":"FT Aires","year":"2014","unstructured":"Aires\u00a0FT, Dedivitis\u00a0RA, Castro\u00a0MA, Bernardo\u00a0WM, Cernea\u00a0CR, Brand\u00e3o\u00a0LG (2014) Efficacy of stapler pharyngeal closure after total laryngectomy: a\u00a0systematic review. Head Neck 36:739\u2013742. https:\/\/doi.org\/10.1002\/hed.23326","journal-title":"Head Neck"},{"key":"890_CR7","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/lary.24466","volume":"124","author":"NA Khan","year":"2014","unstructured":"Khan\u00a0NA, Medina\u00a0JE, Sanclement\u00a0JA, Krempl\u00a0GA (2014) Fistula rates after salvage laryngectomy: comparing pectoralis myofascial and myocutaneous flaps. Laryngoscope 124:1615\u20131617. https:\/\/doi.org\/10.1002\/lary.24466","journal-title":"Laryngoscope"},{"key":"890_CR8","first-page":"162","volume":"35","author":"L Putten","year":"2015","unstructured":"Putten\u00a0L, Bree\u00a0R, Doornaert\u00a0PA, Buter\u00a0J, Eerenstein\u00a0SE, Rietveld\u00a0DH et al (2015) Salvage surgery in post-chemoradiation laryngeal and hypopharyngeal carcinoma: outcome and review. Acta Otorhinolaryngol Ital 35:162\u2013172","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"890_CR9","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1200\/JCO.2013.49.1332","volume":"31","author":"R Haddad","year":"2013","unstructured":"Haddad\u00a0R (2013) Larynx preservation: a\u00a0debate worth preserving. J\u00a0Clin Oncol 31:3170. https:\/\/doi.org\/10.1200\/JCO.2013.49.1332","journal-title":"J Clin Oncol"},{"key":"890_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/archotol.129.1.44","volume":"129","author":"RS Weber","year":"2003","unstructured":"Weber\u00a0RS, Berkey\u00a0BA, Forastiere\u00a0A, Cooper\u00a0J, Maor\u00a0M, Goepfert\u00a0H et\u00a0al (2003) Outcome of salvage total laryngectomy following organ preservation therapy. Arch Otolaryngol Head Neck Surg 129:44. https:\/\/doi.org\/10.1001\/archotol.129.1.44","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"890_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1097\/MLG.0b013e3180332e39","volume":"117","author":"KP Withrow","year":"2007","unstructured":"Withrow\u00a0KP, Rosenthal\u00a0EL, Gourin\u00a0CG, Peters\u00a0GE, Magnuson\u00a0JS, Terris\u00a0DJ et\u00a0al (2007) Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope 117:781\u2013784. https:\/\/doi.org\/10.1097\/MLG.0b013e3180332e39","journal-title":"Laryngoscope"},{"key":"890_CR12","first-page":"2","volume":"27","author":"RA Dedivitis","year":"2007","unstructured":"Dedivitis\u00a0RA, Ribeiro\u00a0KC, Castro\u00a0MA, Nascimento\u00a0PC (2007) Pharyngocutaneous fistula following total laryngectomy. Acta Otorhinolaryngol Ital 27:2\u20135","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"890_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/hed.20502","volume":"29","author":"P Zb\u00e4ren","year":"2007","unstructured":"Zb\u00e4ren\u00a0P, Nuyens\u00a0M, Curschmann\u00a0J, Stauffer\u00a0E (2007) Histologic characteristics and tumor spread of recurrent glottic carcinoma: analysis on whole-organ sections and comparison with tumor spread of primary glottic carcinomas. Head Neck 29:26\u201332. https:\/\/doi.org\/10.1002\/hed.20502","journal-title":"Head Neck"},{"key":"890_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.ijrobp.2008.10.047","volume":"73","author":"JL Lefebvre","year":"2009","unstructured":"Lefebvre\u00a0JL, Ang\u00a0KK (2009) Larynx preservation consensus panel: larynx preservation clinical trial design: key issues and recommendations\u2014a consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293\u20131303. https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.047","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"890_CR15","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/cncr.29241","volume":"121","author":"DI Rosenthal","year":"2015","unstructured":"Rosenthal\u00a0DI, Mohamed\u00a0AS, Weber\u00a0RS, Garden\u00a0AS, Sevak\u00a0PR, Kies\u00a0MS et al (2015) Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a\u00a03-decade survey. Cancer 121:1608\u20131619. https:\/\/doi.org\/10.1002\/cncr.29241","journal-title":"Cancer"},{"key":"890_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ijrobp.2015.03.004","volume":"92","author":"S Grover","year":"2015","unstructured":"Grover\u00a0S, Swisher-McClure\u00a0S, Mitra\u00a0N, Li\u00a0J, Cohen\u00a0RB, Ahn\u00a0PH et al (2015) Total laryngectomy versus larynx preservation for t4a larynx cancer: patterns of care and survival outcomes. Int J Radiat Oncol Biol Phys 92:594\u2013601. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.03.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"890_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1002\/hed.23789","volume":"37","author":"AJ Timmermans","year":"2015","unstructured":"Timmermans\u00a0AJ, de Gooijer\u00a0CJ, Hamming-Vrieze\u00a0O, Hilgers\u00a0FJ, van den Brekel\u00a0MW (2015) T3\u2013T4 laryngeal cancer in The Netherlands Cancer Institute: 10-year results of the consistent application of an organ-preserving\/-sacrificing protocol. Head Neck 37:1495\u20131503. https:\/\/doi.org\/10.1002\/hed.23789","journal-title":"Head Neck"},{"issue":"Suppl. 1","key":"890_CR18","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s00405-008-0697-6","volume":"265","author":"A Dietz","year":"2008","unstructured":"Dietz\u00a0A, Boehm\u00a0A, Mozet\u00a0C, Wichmann\u00a0G, Giannis\u00a0A (2008) Current aspects of targeted therapy in head and neck tumors. Eur Arch Otorhinolaryngol 265(Suppl. 1):S3\u2013S12. https:\/\/doi.org\/10.1007\/s00405-008-0697-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"890_CR19","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"JB Vermorken","year":"2007","unstructured":"Vermorken\u00a0JB, Remenar\u00a0E, van Herpen\u00a0C, Gorlia\u00a0T, Mesia\u00a0R, Degardin\u00a0M et\u00a0al (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N\u00a0Engl J Med 357:1695\u20131704. https:\/\/doi.org\/10.1056\/NEJMoa071028","journal-title":"N Engl J Med"},{"key":"890_CR20","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner\u00a0MR, Hershock\u00a0DM, Blajman\u00a0CR (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N\u00a0Engl J Med 357:1705\u20131715. https:\/\/doi.org\/10.1056\/NEJMoa070956","journal-title":"N Engl J Med"},{"key":"890_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/annonc\/mdy102","volume":"29","author":"RI Haddad","year":"2018","unstructured":"Haddad\u00a0RI, Posner\u00a0M, Hitt\u00a0R, Cohen\u00a0EEW, Schulten\u00a0J, Lefebvre\u00a0JL et\u00a0al (2018) Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. Ann Oncol 29:1130\u20131140. https:\/\/doi.org\/10.1093\/annonc\/mdy102","journal-title":"Ann Oncol"},{"key":"890_CR22","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/jnci\/djp007","volume":"101","author":"Y Pointreau","year":"2009","unstructured":"Pointreau\u00a0Y, Garaud\u00a0P, Chapet\u00a0S (2009) Randomized trial of induction chemotherapy with cisplatin and 5\u2011fluorouracil with or without docetaxel for larynx preservation. J\u00a0Natl Cancer Inst 101:498\u2013506. https:\/\/doi.org\/10.1093\/jnci\/djp007","journal-title":"J Natl Cancer Inst"},{"key":"890_CR23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00405-008-0846-y","volume":"266","author":"A Dietz","year":"2009","unstructured":"Dietz\u00a0A, Rudat\u00a0V, Dreyhaupt\u00a0J, Pritsch\u00a0M, Hoppe\u00a0F, Hagen\u00a0R et al (2009) Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). Eur Arch Otorhinolaryngol 266:1291\u20131300. https:\/\/doi.org\/10.1007\/s00405-008-0846-y","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"053422","key":"890_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner\u00a0JA, Harari\u00a0PM, Giralt\u00a0J, Azarnia\u00a0N, Shin\u00a0DM, Cohen\u00a0RB et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N\u00a0Engl J Med 354(053422):567\u2013578. https:\/\/doi.org\/10.1056\/NEJMoa","journal-title":"N Engl J Med"},{"key":"890_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"JA Bonner","year":"2010","unstructured":"Bonner\u00a0JA, Harari\u00a0PM, Giralt\u00a0J, Cohen\u00a0RB, Jones\u00a0CU, Sur\u00a0RK et al (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5\u2011year survival data from a\u00a0phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21\u201328. https:\/\/doi.org\/10.1016\/S1470-2045(09)70311-0","journal-title":"Lancet Oncol"},{"key":"890_CR26","series-title":"EudraCT-Nr.\u00a02006-006091-38, Clinical trials.gov, NCT00508664","volume-title":"DeLOS-II. Randomised phase II screening study to the use of a\u00a0TPF-chemotherapy (short induction) before TPF induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx\/hypopharynx","author":"A Dietz","year":"2007","unstructured":"Dietz\u00a0A, Wichmann\u00a0G, Kuhnt\u00a0T, Pfreundner\u00a0L, Hagen\u00a0R, Scheich\u00a0M (2007) DeLOS-II. Randomised phase II screening study to the use of a\u00a0TPF-chemotherapy (short induction) before TPF induction, radiotherapy with or without cetuximab in the primary therapy of the only by laryngectomy operable carcinoma of the larynx\/hypopharynx. EudraCT-Nr.\u00a02006-006091-38, Clinical trials.gov, NCT00508664"},{"key":"890_CR27","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1055\/s-0038-1640003","volume":"29","author":"A Dietz","year":"2018","unstructured":"Dietz\u00a0A, Wichmann\u00a0G, Kuhnt\u00a0T, Pfreundner\u00a0L, Hagen\u00a0R, Scheich\u00a0M et al (2018) Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal\/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II. Ann Oncol 29:2105\u20132114. https:\/\/doi.org\/10.1055\/s-0038-1640003","journal-title":"Ann Oncol"},{"key":"890_CR28","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa031317","volume":"349","author":"AA Forastiere","year":"2003","unstructured":"Forastiere\u00a0AA, Goepfert\u00a0H, Maor\u00a0M, Pajak\u00a0TF, Weber\u00a0R, Morrison\u00a0W et\u00a0al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N\u00a0Engl J Med 349:2091\u20132098. https:\/\/doi.org\/10.1056\/NEJMoa031317","journal-title":"N Engl J Med"},{"key":"890_CR29","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00066-013-0411-5","volume":"189","author":"T Rutkowski","year":"2013","unstructured":"Rutkowski\u00a0T, Wygoda\u00a0A, Sk\u0142adowski\u00a0K, Hejduk\u00a0B, Rutkowski\u00a0R, Ko\u0142osza\u00a0Z et\u00a0al (2013) Prognostic role of tumor volume for radiotherapy outcome in patient with T2 laryngeal cancer. Strahlenther Onkol 189:861\u2013866. https:\/\/doi.org\/10.1007\/s00066-013-0411-5","journal-title":"Strahlenther Onkol"},{"key":"890_CR30","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1002\/ijc.29649","volume":"137","author":"G Wichmann","year":"2015","unstructured":"Wichmann\u00a0G, Rosolowski\u00a0M, Krohn\u00a0K, Kreuz\u00a0M, Boehm\u00a0A, Reiche\u00a0A et al (2015) The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer. Int J Cancer 137:2846\u20132857. https:\/\/doi.org\/10.1002\/ijc.29649","journal-title":"Int J Cancer"},{"key":"890_CR31","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1172\/JCI67010","volume":"123","author":"E Kostareli","year":"2013","unstructured":"Kostareli\u00a0E, Holzinger\u00a0D, Bogatyrova\u00a0O, Hielscher\u00a0T, Wichmann\u00a0G, Keck\u00a0M et al (2013) HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas. J\u00a0Clin Invest 123:2488\u20132501. https:\/\/doi.org\/10.1172\/JCI67010","journal-title":"J Clin Invest"},{"key":"890_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/15592294.2015.1137414","volume":"11","author":"E Kostareli","year":"2016","unstructured":"Kostareli\u00a0E, Hielscher\u00a0T, Zucknick\u00a0M, Baboci\u00a0L, Wichmann\u00a0G, Holzinger\u00a0D et\u00a0al (2016) Gene promoter methylation signature predicts survival of head and neck squamous cell carcinoma patients. Epigenetics 11:61\u201373. https:\/\/doi.org\/10.1080\/15592294.2015.1137414","journal-title":"Epigenetics"},{"key":"890_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/cncr.29188","volume":"121","author":"S Semrau","year":"2015","unstructured":"Semrau\u00a0S, Haderlein\u00a0M, Schmidt\u00a0D, Lell\u00a0M, Wolf\u00a0W, Waldfahrer\u00a0F et al (2015) Single-cycle induction chemotherapy followed by chemoradiotherapy or surgery in patients with head and neck cancer: what are the best predictors of remission and prognosis? Cancer 121:1214\u20131222. https:\/\/doi.org\/10.1002\/cncr.29188","journal-title":"Cancer"},{"key":"890_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejca.2016.11.013","volume":"72","author":"G Wichmann","year":"2017","unstructured":"Wichmann\u00a0G, Kr\u00fcger\u00a0A, Boehm\u00a0A, Kolb\u00a0M, Hofer\u00a0M, Fischer\u00a0M et al (2017) Induction chemotherapy followed by radiotherapy for larynx preservation in advanced laryngeal and hypopharyngeal cancer: outcome prediction after one cycle induction chemotherapy by a\u00a0score based on clinical evaluation, computed tomography-based volumetry and 18\u202fF-FDG-PET\/CT. Eur J Cancer 72:144\u2013155. https:\/\/doi.org\/10.1016\/j.ejca\u00a0.2016.11.013","journal-title":"Eur J Cancer"},{"key":"890_CR35","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJM199106133242402","volume":"324","author":"The Department of Veterans Affairs Laryngeal Cancer Study Group","year":"1991","unstructured":"The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N\u00a0Engl J Med 324:1685\u20131690. https:\/\/doi.org\/10.1056\/NEJM199106133242402","journal-title":"N Engl J Med"},{"issue":"2","key":"890_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/emboj.2012.333","volume":"32","author":"B Heemskerk","year":"2013","unstructured":"Heemskerk\u00a0B, Kvistborg\u00a0P, Schumacher\u00a0TN (2013) The cancer antigenome. EMBO\u00a0J 32(2):194\u2013203. https:\/\/doi.org\/10.1038\/emboj.2012.333","journal-title":"EMBO J"},{"key":"890_CR37","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fonc.2019.00191","volume":"9","author":"S Wiegand","year":"2019","unstructured":"Wiegand\u00a0S, Wichmann\u00a0G, Dietz\u00a0A (2019) Perspectives of induction with chemo and\/or immune check point inhibition in head and neck organ preservation treatment. Front Oncol 9:191. https:\/\/doi.org\/10.3389\/fonc.2019.00191","journal-title":"Front Oncol"},{"issue":"12","key":"890_CR38","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1158\/2159-8290.CD-16-0577","volume":"6","author":"J Liu","year":"2016","unstructured":"Liu\u00a0J, Blake\u00a0SJ, Yong\u00a0MC, Harjunp\u00e4\u00e4\u00a0H, Ngiow\u00a0SF, Takeda\u00a0K, Young\u00a0A, O\u2019Donnell\u00a0JS, Allen\u00a0S, Smyth\u00a0MJ, Teng\u00a0MW (2016) Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease. Cancer Discov 6(12):1382\u20131399","journal-title":"Cancer Discov"},{"key":"890_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMe1803923","volume":"378","author":"TF Gajewski","year":"2018","unstructured":"Gajewski\u00a0TF (2018) Fast forward\u2014neoadjuvant cancer immunotherapy. N\u00a0Engl J Med 378:21","journal-title":"N Engl J Med"},{"issue":"9","key":"890_CR40","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1056\/NEJMc1808251","volume":"379","author":"PM Forde","year":"2018","unstructured":"Forde\u00a0PM, Chaft\u00a0JE, Pardoll\u00a0DM (2018) Neoadjuvant PD\u20111 blockade in resectable lung cancer. N\u00a0Engl J Med 379(9):e14. https:\/\/doi.org\/10.1056\/NEJMc1808251","journal-title":"N Engl J Med"},{"key":"890_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.bjc.6605465","volume":"102","author":"WM Liu","year":"2010","unstructured":"Liu\u00a0WM, Fowler\u00a0DW, Smith\u00a0P, Dalgleish\u00a0AG (2010) Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses. Br J Cancer 102:115\u2013123. https:\/\/doi.org\/10.1038\/sj.bjc.6605465","journal-title":"Br J Cancer"},{"key":"890_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdv615","volume":"27","author":"J Chen","year":"2016","unstructured":"Chen\u00a0J, Jiang\u00a0CC, Jin\u00a0L, Zhang\u00a0XD (2016) Regulation of PD-L1: a\u00a0novel role of pro-survival signaling in cancer. Ann Oncol 27:409\u2013416","journal-title":"Ann Oncol"},{"key":"890_CR43","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1158\/0008-5472.CAN-14-3098","volume":"75","author":"J Peng","year":"2015","unstructured":"Peng\u00a0J, Hamanishi\u00a0J, Matsumura\u00a0N, Abiko\u00a0K, Murat\u00a0K, Baba\u00a0T et al (2015) Chemotherapy induces programmed cell death-ligand 1 overexpression via the nuclear factor-\u03baB to foster an immunosuppressive tumor microenvironment in ovarian cancer. Cancer Res 75:5034\u20135045. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3098","journal-title":"Cancer Res"},{"key":"890_CR44","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/cas.13072","volume":"107","author":"P Zhang","year":"2016","unstructured":"Zhang\u00a0P, Ma\u00a0Y, Lv\u00a0C, Huang\u00a0M, Li\u00a0M, Dong\u00a0B et al (2016) The up-regulation of PD-L1 promotes the resistant response in non-small cell lung cancer patients with neo- adjuvant chemotherapy. Cancer Sci 107:1563\u20131571. https:\/\/doi.org\/10.1111\/cas.13072","journal-title":"Cancer Sci"},{"key":"890_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41199-020-00052-8","volume":"5","author":"M Stafford","year":"2020","unstructured":"Stafford\u00a0M, Kaczmar\u00a0J (2020) The neoadjuvant paradigm reinvigorated: a\u00a0review of pre-surgical immunotherapy in HNSCC. Cancers Head Neck 5:4. https:\/\/doi.org\/10.1186\/s41199-020-00052-8","journal-title":"Cancers Head Neck"},{"issue":"15_suppl","key":"890_CR46","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1200\/JCO.2019.37.15_suppl.2574","volume":"37","author":"J Horton","year":"2019","unstructured":"Horton\u00a0J, Knochelmann\u00a0H, Armeson\u00a0K, Kaczmar\u00a0J, Paulos\u00a0C, Neskey\u00a0D (2019) Neoadjuvant presurgical PD\u20111 inhibition in oral cavity squamous cell carcinoma. J\u00a0Clin Oncol 37(15_suppl):2574","journal-title":"J Clin Oncol"},{"issue":"15 Suppl","key":"890_CR47","doi-asserted-by":"publisher","first-page":"abstr 6012","DOI":"10.1200\/JCO.2017.35.15_suppl.6012","volume":"35","author":"R Uppaluri","year":"2017","unstructured":"Uppaluri\u00a0R, Zolkind\u00a0P, Lin\u00a0T, Nussenbaum\u00a0B, Jackson\u00a0RS, Rich\u00a0J et\u00a0al (2017) Neoadjuvant pembrolizumab in surgically resectable, locally advanced HPVnegative head and neck squamous cell carcinoma (HNSCC). J\u00a0Clin Oncol 35(15 Suppl):abstr 6012","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"890_CR48","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1200\/JCO.2018.36.15_suppl.6017","volume":"6","author":"TM Wise-Draper","year":"2018","unstructured":"Wise-Draper\u00a0TM, Old\u00a0MO, Worden\u00a0FP, O\u2019Brien\u00a0PE, Cohen\u00a0EEW, Dunlap\u00a0N et al (2018) Phase II multi-site investigation of neoadjuvant pembrolizumab and adjuvant concurrent radiation and pembrolizumab with or without cisplatin in resected head and neck squamous cell carcinoma. J\u00a0Clin Oncol 6(15_suppl):6017","journal-title":"J Clin Oncol"},{"issue":"suppl_5","key":"890_CR49","first-page":"v605","volume":"28","author":"RL Ferris","year":"2017","unstructured":"Ferris\u00a0RL, Gon\u00e7alves\u00a0A, Baxi\u00a0AA, Martens\u00a0UM, Gauthier\u00a0H (2017) An open-label, multicohort, phase 1\/2 study in patients with virus-associated cancers (CheckMate 358): safety and efficacy of neoadjuvant nivolumab in squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 28(suppl_5):v605\u2013V649","journal-title":"Ann Oncol"},{"key":"890_CR50","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/jamaoncol.2017.4478","volume":"4","author":"MC Simpson","year":"2018","unstructured":"Simpson\u00a0MC, Massa\u00a0ST, Boakye\u00a0EA, Antisdel\u00a0JL, Stamatakis\u00a0KA, Varvares\u00a0MA et\u00a0al (2018) Primary cancer vs competing causes of death in survivors of head and neck cancer. JAMA Oncol 4:257\u2013259. https:\/\/doi.org\/10.1001\/jamaoncol.2017.4478","journal-title":"JAMA Oncol"},{"key":"890_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00106-011-2416-7","volume":"60","author":"A Dietz","year":"2012","unstructured":"Dietz\u00a0A, Boehm\u00a0A, Wichmann\u00a0G, Niederwieser\u00a0D, Dietzsch\u00a0S, Fuchs\u00a0M (2012) Multimodaler Larynxerhalt. Wege zur besseren Patientenselektion. HNO 60:19\u201331. https:\/\/doi.org\/10.1007\/s00106-011-2416-7","journal-title":"HNO"},{"key":"890_CR52","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1093\/jnci\/88.13.890","volume":"88","author":"JL Lefebvre","year":"1996","unstructured":"Lefebvre\u00a0JL, Chevalier\u00a0D, Luboinski\u00a0B, Kirkpatrick\u00a0A, Collette\u00a0L, Sahmoud\u00a0T (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a\u00a0European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J\u00a0Natl Cancer Inst 88:890\u2013899. https:\/\/doi.org\/10.1093\/jnci\/88.13.890","journal-title":"J Natl Cancer Inst"},{"key":"890_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/archotol.130.7.875","volume":"130","author":"E Hanna","year":"2004","unstructured":"Hanna\u00a0E, Sherman\u00a0A, Cash\u00a0D, Adams\u00a0D, Vural\u00a0E, Fan\u00a0CY et\u00a0al (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130:875\u2013879. https:\/\/doi.org\/10.1001\/archotol.130.7.875","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"890_CR54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1200\/JOP.2016.014811","volume":"12","author":"A Dietz","year":"2016","unstructured":"Dietz\u00a0A (2016) Functional organ preservation in larynx cancer: a\u00a0continuing debate. J\u00a0Oncol Pract 12:727\u2013728. https:\/\/doi.org\/10.1200\/JOP.2016.014811","journal-title":"J Oncol Pract"},{"key":"890_CR55","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1200\/JCO.2017.75.7385","volume":"24","author":"DG Pfister","year":"2006","unstructured":"Pfister\u00a0DG, Laurie\u00a0SA, Weinstein\u00a0GS, Mendenhall\u00a0WM, Adelstein\u00a0DJ et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J\u00a0Clin Oncol 24:3693\u20133704. https:\/\/doi.org\/10.1200\/JCO.2017.75.7385","journal-title":"J Clin Oncol"},{"key":"890_CR56","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2005.01.2047","volume":"24","author":"S Urba","year":"2006","unstructured":"Urba\u00a0S, Wolf\u00a0G, Eisbruch\u00a0A, Worden\u00a0F, Lee\u00a0J, Bradford\u00a0C et al (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a\u00a0new treatment paradigm. J\u00a0Clin Oncol 24:593\u2013598. https:\/\/doi.org\/10.1200\/JCO.2005.01.2047","journal-title":"J Clin Oncol"},{"key":"890_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00405-018-5241-8","volume":"276","author":"A Al-Mamgani","year":"2019","unstructured":"Al-Mamgani\u00a0A, Navran\u00a0A, Walraven\u00a0I, Schreuder\u00a0WH, Tesselaar\u00a0MET, Klop\u00a0WMC (2019) Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth? Eur Arch Otorhinolaryngol 276:575\u2013583. https:\/\/doi.org\/10.1007\/s00405-018-5241-8","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-020-00890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-020-00890-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-020-00890-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T23:49:58Z","timestamp":1622159398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-020-00890-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,28]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s00106-020-00890-5","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,28]]},"assertion":[{"value":"28 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Dietz, G.\u00a0Wichmann, T.\u00a0Kuhnt und S.\u00a0Wiegand geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}